Us Drug Company
- All
- News
- Videos
-
Apple Receives US FDA Approval to Enable AirPods Pro 2 Hearing Aids Feature
AirPods Pro (2nd Generation) users will be able to use the company's truly wireless stereo (TWS) headset as a hearing aid in the future, as Apple has now received approval from the US Food and Drug Administration (FDA) to enable the feature. An update will also bring support for a new hearing test, which will generate an audio profile for the heari...
-
US FDA Clears Neuralink's Brain Chip Implant in Second Patient: Report
The US Food and Drug Administration has allowed billionaire Elon Musk's Neuralink to implant its brain chip in a second person after the company offered fixes to a problem that occurred in the first patient, the Wall Street Journal reported on Monday.
-
US Approves Lab-Grown Chicken To Be Sold In Markets, Twitter Reacts
The United States Department of Agriculture (USDA) has granted approvals to two companies selling chicken grown from animal cells.
-
Elon Musk Expects Brain-Chip Startup Neuralink to Start First Human Trial This Year
Elon Musk expects his brain-chip startup Neuralink to start its first human trial this year, he said on Friday. While Musk didn't specify how many patients his company would implant or for how long, "it's looking like the first case will be later this year," said Musk.
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Neuralink Said to Approach US Neurosurgery Centre as Potential Human Clinical Trials Partner
Neuralink, Elon Musk's brain implant company, is said to have approached one of the biggest US neurosurgery centres ahead of the company's plans to launch a human clinical trial for its devices that have been in development since 2016. The firm is working to address concerns expressed by the US Food and Drug Administration after it rejected an appl...
-
Johnson & Johnson Loses Key Tuberculosis Drug Patent In India
The Indian Patent Office on Thursday rejected US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
-
Fitbit Rolls Out Irregular Heart Rhythm Notifications to 9 Smartwatches: All the Details
Fitbit has started rolling out Irregular Heart Rhythm Notifications to nine of its products. Fitbit had recently received clearance from the US Food and Drug Administration (FDA) for the company’s new photoplethysmography (PPG) algorithm to identify atrial fibrillation (AFib). The smartwatches that support the new feature includes Fitbit Sense, F...
-
Moderna Seeks Emergency Approval For Second Covid Booster For US Adults
Moderna announced Thursday it had asked the United States drug regulator for emergency authorization for a second booster shot of the company's Covid-19 vaccine for all adults.
-
Samsung in Talks to Buy Alzheimer’s Drug Maker Biogen for $42 Billion: Report
Biogen shares surged following a report that Samsung is in talks to acquire the US biotech company for more than $40 billion (roughly Rs. 2,98,170 crore).
-
Snapchat's New Tool to Educate Users on Drug Dangers Following Fentanyl Deaths in US
Snap, the parent company of popular social media platform Snapchat, has announced a new in-app tool that it says will educate users searching or drug-related key words on Snapchat about the dangers of drugs. The announcement comes after a public safety alert from the US Drug Enforcement Administration (DEA) last week that warned about an increase i...
-
BlackBerry Software Cybersecurity Flaw Could Impact Cars, Medical Devices: US Agencies
A cybersecurity flaw in a software designed by BlackBerry could put at risk cars and medical equipment that use it and expose highly sensitive systems to attackers, the US drugs regulator and a federal agency said.
-
Indian Envoy Meets Top CEOs Of US To Help Country In Covid Crisis
The Indian envoy in the US is having an intense engagement with the CEOs of top American companies, particularly from the pharma sector, to help India get the necessary medical equipment and drugs to successfully combat the COVID-19 pandemic.
-
Cipla To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19 patients.
-
Dawood "Lieutenant" Jabir Moti Appeals Against Extradition From UK To US
Jabir Moti, described in court as a "top lieutenant" of underworld don Dawood Ibrahim's D Company worldwide criminal network, has appealed in the High Court in London against his extradition to the US to face charges of drug trafficking, money laundering and blackmail.
-
Apple Receives US FDA Approval to Enable AirPods Pro 2 Hearing Aids Feature
AirPods Pro (2nd Generation) users will be able to use the company's truly wireless stereo (TWS) headset as a hearing aid in the future, as Apple has now received approval from the US Food and Drug Administration (FDA) to enable the feature. An update will also bring support for a new hearing test, which will generate an audio profile for the heari...
-
US FDA Clears Neuralink's Brain Chip Implant in Second Patient: Report
The US Food and Drug Administration has allowed billionaire Elon Musk's Neuralink to implant its brain chip in a second person after the company offered fixes to a problem that occurred in the first patient, the Wall Street Journal reported on Monday.
-
US Approves Lab-Grown Chicken To Be Sold In Markets, Twitter Reacts
The United States Department of Agriculture (USDA) has granted approvals to two companies selling chicken grown from animal cells.
-
Elon Musk Expects Brain-Chip Startup Neuralink to Start First Human Trial This Year
Elon Musk expects his brain-chip startup Neuralink to start its first human trial this year, he said on Friday. While Musk didn't specify how many patients his company would implant or for how long, "it's looking like the first case will be later this year," said Musk.
-
Elon Musk's Neuralink Says It Has FDA Approval for Study of Brain Implants in Humans
Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
-
Neuralink Said to Approach US Neurosurgery Centre as Potential Human Clinical Trials Partner
Neuralink, Elon Musk's brain implant company, is said to have approached one of the biggest US neurosurgery centres ahead of the company's plans to launch a human clinical trial for its devices that have been in development since 2016. The firm is working to address concerns expressed by the US Food and Drug Administration after it rejected an appl...
-
Johnson & Johnson Loses Key Tuberculosis Drug Patent In India
The Indian Patent Office on Thursday rejected US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
-
Fitbit Rolls Out Irregular Heart Rhythm Notifications to 9 Smartwatches: All the Details
Fitbit has started rolling out Irregular Heart Rhythm Notifications to nine of its products. Fitbit had recently received clearance from the US Food and Drug Administration (FDA) for the company’s new photoplethysmography (PPG) algorithm to identify atrial fibrillation (AFib). The smartwatches that support the new feature includes Fitbit Sense, F...
-
Moderna Seeks Emergency Approval For Second Covid Booster For US Adults
Moderna announced Thursday it had asked the United States drug regulator for emergency authorization for a second booster shot of the company's Covid-19 vaccine for all adults.
-
Samsung in Talks to Buy Alzheimer’s Drug Maker Biogen for $42 Billion: Report
Biogen shares surged following a report that Samsung is in talks to acquire the US biotech company for more than $40 billion (roughly Rs. 2,98,170 crore).
-
Snapchat's New Tool to Educate Users on Drug Dangers Following Fentanyl Deaths in US
Snap, the parent company of popular social media platform Snapchat, has announced a new in-app tool that it says will educate users searching or drug-related key words on Snapchat about the dangers of drugs. The announcement comes after a public safety alert from the US Drug Enforcement Administration (DEA) last week that warned about an increase i...
-
BlackBerry Software Cybersecurity Flaw Could Impact Cars, Medical Devices: US Agencies
A cybersecurity flaw in a software designed by BlackBerry could put at risk cars and medical equipment that use it and expose highly sensitive systems to attackers, the US drugs regulator and a federal agency said.
-
Indian Envoy Meets Top CEOs Of US To Help Country In Covid Crisis
The Indian envoy in the US is having an intense engagement with the CEOs of top American companies, particularly from the pharma sector, to help India get the necessary medical equipment and drugs to successfully combat the COVID-19 pandemic.
-
Cipla To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19 patients.
-
Dawood "Lieutenant" Jabir Moti Appeals Against Extradition From UK To US
Jabir Moti, described in court as a "top lieutenant" of underworld don Dawood Ibrahim's D Company worldwide criminal network, has appealed in the High Court in London against his extradition to the US to face charges of drug trafficking, money laundering and blackmail.
